Jasper Therapeutics Files Definitive Proxy Statement
Ticker: JSPRW · Form: DEF 14A · Filed: May 19, 2025 · CIK: 1788028
| Field | Detail |
|---|---|
| Company | Jasper Therapeutics, Inc. (JSPRW) |
| Form Type | DEF 14A |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, sec-filing
Related Tickers: JSPR
TL;DR
Jasper Therapeutics (JSPR) filed its DEF 14A proxy statement on 5/19/25. Get ready for shareholder votes.
AI Summary
Jasper Therapeutics, Inc. filed a Definitive Proxy Statement (DEF 14A) on May 19, 2025, for its fiscal year ending December 31, 2025. The company, formerly known as Amplitude Healthcare Acquisition Corp until September 12, 2019, is involved in the biological products sector. The filing is related to the company's proxy materials for its shareholders.
Why It Matters
This filing provides shareholders with essential information regarding upcoming shareholder meetings and voting matters, impacting corporate governance and strategic decisions.
Risk Assessment
Risk Level: low — A DEF 14A filing is a routine disclosure of proxy information and does not inherently indicate new risks.
Key Numbers
- 20250703 — Report Period End Date (Indicates the period for which the proxy statement is relevant.)
- 20250519 — Filing Date (The date the definitive proxy statement was submitted to the SEC.)
Key Players & Entities
- Jasper Therapeutics, Inc. (company) — Registrant
- Amplitude Healthcare Acquisition Corp (company) — Former company name
- 20250519 (date) — Filing date
- 20250703 (date) — Report period end date
- 2200 BRIDGE PKWY SUITE #102 (address) — Company business and mailing address
- REDWOOD CITY, CA (address) — Company business and mailing city/state
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing is a Definitive Proxy Statement filed with the SEC by a company to provide shareholders with information about matters to be voted on at an upcoming shareholder meeting.
When was Jasper Therapeutics, Inc. formerly known as Amplitude Healthcare Acquisition Corp?
Jasper Therapeutics, Inc. was formerly known as Amplitude Healthcare Acquisition Corp until a name change on September 12, 2019.
What is the fiscal year end for Jasper Therapeutics, Inc.?
The fiscal year end for Jasper Therapeutics, Inc. is December 31.
Where is Jasper Therapeutics, Inc. located?
Jasper Therapeutics, Inc. is located at 2200 Bridge Pkwy Suite #102, Redwood City, CA 94065.
What is the SEC file number for Jasper Therapeutics, Inc.?
The SEC file number for Jasper Therapeutics, Inc. is 001-39138.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 19, 2025 regarding Jasper Therapeutics, Inc. (JSPRW).